| Description | Setrusumab (BPS 804) is a fully humanized monoclonal antibody targeting sclerostin, effectively enhancing bone strength. It is utilized in research on Osteogenesis Imperfecta (OI) and cancer [1]. |
| In vivo | Setrusumab（100 mg/kg；每周一次，静脉注射，持续4周）在小鼠模型中有效抑制乳腺癌引起的骨转移和肌肉无力现象[1]。 |
| Synonyms | BPS 804 |
| molecular weight | N/A |
| CAS | 1847394-95-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years | Shipping with blue ice. |